Early research (Phase 1)Study completedNCT02944474
What this trial is testing
Assess the Safety, Tolerability and Pharmacokinetics of Lucerastat (CDP923) After Multiple Dosing in Healthy Subjects
Who this might be right for
Healthy Subjects
Idorsia Pharmaceuticals Ltd. 37